901 related articles for article (PubMed ID: 18206907)
1. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
Hou T; Zhang W; Case DA; Wang W
J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
[TBL] [Abstract][Full Text] [Related]
2. Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.
Hou T; McLaughlin W; Lu B; Chen K; Wang W
J Proteome Res; 2006 Jan; 5(1):32-43. PubMed ID: 16396493
[TBL] [Abstract][Full Text] [Related]
3. Modeling and prediction of binding affinities between the human amphiphysin SH3 domain and its peptide ligands using genetic algorithm-Gaussian processes.
Zhou P; Tian F; Chen X; Shang Z
Biopolymers; 2008; 90(6):792-802. PubMed ID: 18814309
[TBL] [Abstract][Full Text] [Related]
4. Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides.
Wiedemann U; Boisguerin P; Leben R; Leitner D; Krause G; Moelling K; Volkmer-Engert R; Oschkinat H
J Mol Biol; 2004 Oct; 343(3):703-18. PubMed ID: 15465056
[TBL] [Abstract][Full Text] [Related]
5. Factor analysis scales of generalized amino acid information as applied in predicting interactions between the human amphiphysin-1 SH3 domains and their peptide ligands.
Liang G; Chen G; Niu W; Li Z
Chem Biol Drug Des; 2008 Apr; 71(4):345-51. PubMed ID: 18318694
[TBL] [Abstract][Full Text] [Related]
6. SH3-SPOT: an algorithm to predict preferred ligands to different members of the SH3 gene family.
Brannetti B; Via A; Cestra G; Cesareni G; Helmer-Citterich M
J Mol Biol; 2000 Apr; 298(2):313-28. PubMed ID: 10764600
[TBL] [Abstract][Full Text] [Related]
7. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
8. Toward quantitative characterization of the binding profile between the human amphiphysin-1 SH3 domain and its peptide ligands.
He P; Wu W; Wang HD; Yang K; Liao KL; Zhang W
Amino Acids; 2010 Apr; 38(4):1209-18. PubMed ID: 19669081
[TBL] [Abstract][Full Text] [Related]
9. Recognition of non-canonical peptides by the yeast Fus1p SH3 domain: elucidation of a common mechanism for diverse SH3 domain specificities.
Kim J; Lee CD; Rath A; Davidson AR
J Mol Biol; 2008 Mar; 377(3):889-901. PubMed ID: 18280496
[TBL] [Abstract][Full Text] [Related]
10. Predicting protein-peptide interactions via a network-based motif sampler.
Reiss DJ; Schwikowski B
Bioinformatics; 2004 Aug; 20 Suppl 1():i274-82. PubMed ID: 15262809
[TBL] [Abstract][Full Text] [Related]
11. Computational analysis and prediction of the binding motif and protein interacting partners of the Abl SH3 domain.
Hou T; Chen K; McLaughlin WA; Lu B; Wang W
PLoS Comput Biol; 2006 Jan; 2(1):e1. PubMed ID: 16446784
[TBL] [Abstract][Full Text] [Related]
12. Comparative structural and energetic analysis of WW domain-peptide interactions.
Schleinkofer K; Wiedemann U; Otte L; Wang T; Krause G; Oschkinat H; Wade RC
J Mol Biol; 2004 Nov; 344(3):865-81. PubMed ID: 15533451
[TBL] [Abstract][Full Text] [Related]
13. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
Liu J; Li M; Ran X; Fan JS; Song J
Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
[TBL] [Abstract][Full Text] [Related]
14. Recognition of lysine-rich peptide ligands by murine cortactin SH3 domain: CD, ITC, and NMR studies.
Rubini C; Ruzza P; Spaller MR; Siligardi G; Hussain R; Udugamasooriya DG; Bellanda M; Mammi S; Borgogno A; Calderan A; Cesaro L; Brunati AM; Donella-Deana A
Biopolymers; 2010; 94(3):298-306. PubMed ID: 19921743
[TBL] [Abstract][Full Text] [Related]
15. Domain Interaction Footprint: a multi-classification approach to predict domain-peptide interactions.
Schillinger C; Boisguerin P; Krause G
Bioinformatics; 2009 Jul; 25(13):1632-9. PubMed ID: 19376827
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
Pisabarro MT; Serrano L; Wilmanns M
J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the SH3 domain of betaPIX in complex with a high affinity peptide from PAK2.
Hoelz A; Janz JM; Lawrie SD; Corwin B; Lee A; Sakmar TP
J Mol Biol; 2006 Apr; 358(2):509-22. PubMed ID: 16527308
[TBL] [Abstract][Full Text] [Related]
18. Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.
Wu C; Ma MH; Brown KR; Geisler M; Li L; Tzeng E; Jia CY; Jurisica I; Li SS
Proteomics; 2007 Jun; 7(11):1775-85. PubMed ID: 17474147
[TBL] [Abstract][Full Text] [Related]
19. Comparison of binding energies of SrcSH2-phosphotyrosyl peptides with structure-based prediction using surface area based empirical parameterization.
Henriques DA; Ladbury JE; Jackson RM
Protein Sci; 2000 Oct; 9(10):1975-85. PubMed ID: 11106171
[TBL] [Abstract][Full Text] [Related]
20. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures.
Larson SM; Davidson AR
Protein Sci; 2000 Nov; 9(11):2170-80. PubMed ID: 11152127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
